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Acute Lymphoblastic Leukemia (ALL) is the most common type of childhood cancer. 
According to the American Cancer Society 3 out of 4 childhood leukemia cases are ALL, and the 
main treatment for these patients is chemotherapy. There are various tools that doctors and 
nurses use in order to effectively communicate with these young patients and their families about 
what this type of leukemia is, and what chemotherapy will do in order to help. There are 
children’s books on cancer, but they are mostly coping aids or answer general questions. My 
children’s e-book however invites the young reader (6 to 14-year-olds) into the world of immune 
cells, by following the life of a T-cell as he learns about his environment and how to interact 
with other immune cells to fight against ALL and protect their human. The reader also witnesses 
how the cells react to the chemotherapy, and their journey after treatment. My goal for this 
creative project is that it will serve as another educational tool for patients with ALL. Also, I 
hope that it inspires its audience and gets them excited about science. Even though this children’s 
book is written with scientific detail, the concepts are presented in a simple and attainable way, 
enabling my young audience to comprehend what ALL is, unlocking their perception towards the 
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 Acute Lymphoblastic Leukemia (ALL) is a cancer of the bone marrow, hence the name 
leukemia, started by early forms of white blood cells also called lymphocytes, that is quickly 
growing or spreading for which it receives the name acute (cancer.org, 2019). ALL is the result 
of a mutation in immature B cells that causes them to quickly replicate into multiple cells 
carrying the mutation (clones in the story). ALL occurs mostly in children between the ages of 6 
and 14 years old, but can occur at any age whether infant or adult. Lastly, current survival rates 
include a percentage of 98% of pediatric patients enter into remission within weeks of starting 
treatment, and 90% of those pediatric cases can be cured after 10 years of remission (stjude.org, 
2019). 
The reason for why I chose to write about ALL is because out of all childhood leukemias, 
ALL occurs in about 3 out of 4 pediatric leukemia patients (American Cancer Society, 2019). I 
wanted to write a story that would be relatable to most pediatric patients. What separates ALL 
from other types of leukemia and cancers, is that it’s a cancer of the bone marrow by B cell or T 
cell mutation, which clones quickly and can spread throughout the body via the blood. For this 
story, in order to not confuse the audience, I chose to have the B cells start the cancer and the T 
cells remain unaffected by the mutation. According to the cancer.org website, this type of 
leukemia can spread to the patient’s lymph nodes, central nervous system, liver, spleen, and 
other organs (this varies depending on the patient). Scientists and researchers are finding that 
there are several factors that could cause or provoke childhood leukemia. These are called risk 
factors, which include: genetic, lifestyle-related, and environmental factors. Among the genetic 
risk factors that come from the parent’s bloodline, genetic syndromes like Down syndrome, 
inherited immune system problems such as Bloom syndrome and Schwachman-Diamond 
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syndrome, and having a sibling with leukemia are included as risk factors for developing ALL 
(American Cancer Society, 2019). Lifestyle-related risk factors, that are more for an adult’s 
chance of developing ALL, include: being overweight, smoking, too much exposure to the sun, 
and excessive consumption of alcohol. Environmental risk factors, are outside influences that 
have an effect on a person’s physiology. These include high levels of radiation exposure, 
exposure to chemotherapy drugs like etoposide and cyclophosphamide while treating a previous 
cancer, or other chemicals like benzene, and immune system suppression due to intensive 
treatment (like an organ transplant). Besides these possible risk factors, there are not many 
known lifestyle or environmental risk factors directly linked to ALL. Therefore, there are no 
known preventions for ALL as of now. This is significant in understanding that in the majority of 
ALL cases, there is nothing that could have been done in order to prevent its development in the 
patient (American Cancer Society, 2019). Neo, the B-cell in my story that sorrowfully and 
inexplicably carried the mutation for ALL, was my way of showing the audience this idea of 
unpredictability.  
When it comes to treatments, chemotherapy is the main treatment for ALL. 
Chemotherapy is usually induced in 3 phases that can span over a time of 2 to 3 years. These 
phases are called Induction, Consolidation, and Maintenance (St. Jude’s, 2019). I would like to 
discuss the Induction phase, since it is the first phase of chemotherapy and it’s the phase that my 
story ends with. During Induction, patients typically receive a combination of 3 drugs for their 
first month of treatment. These chemotherapy drugs are L-asparaginase and vincristine, and 
usually dexamethasone (a steroid drug) (American Cancer Society, 2019). I illustrate these drugs 
as little star-shaped molecules with 3 different colors for the 3 different drugs. I also write 
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“About 1 Month Later” toward the end of the story in order to keep a timeline of how long it has 
been after the Induction phase. 
Consulting the sources listed in my bibliography is how I derived ideas and inspiration 
for my own interpretation of how immune cells look and the overall plot of the story. I did this in 
order to represent ALL and these immune cells in their roles and physiological interactions. This 
contextual information is what influenced me both theoretically and artistically in my drawings 
and story for this creative project. I wished to achieve an eye-catching and relatable story that 
ALL patients could gain insight to, and readers not impacted by ALL in their lives could also 
learn about ALL from this creative project. Hopefully I accomplished making this story relatable 
by taking the creative freedom to personify the cells by giving them facial features and feelings. I 
wanted the audience to see themselves in my characters, so that it would be easier for them to 
stay engaged in these cells’ journey through ALL. Although I took creative freedom in how I 
illustrated and simplified ideas, I tried my best to stay true to the nature of these cells and ALL. 
My first goal was to make this children’s book a good starting point for anyone interested in 
understanding how ALL works. My second goal was to spark inquisitiveness in the reader for 
these cells and the scientific field that studies them. I learned a great deal about ALL through 
making this book. From how the cells interact with each other, to how the chemotherapy affects 
these cells during and after treatment. I wish that I would have drawn some things like the cell 
receptors with more detail, or included Chimeric Antigen Receptor T cell therapy (CAR T 
therapy) as an immunotherapy option, but perhaps this is a revision I could do in the future. 
Thank you for reading, hopefully like me, you have a new insight of ALL and the immune cells 




Cast of Characters 
While I was creating characters for my book, I kept in mind that I wanted to introduce the 
audience to the leading cells that are front-and-center in the fight against cancer. 
Tim 
Tim is a Cytotoxic T cell, he is one of the main characters of my story, and also one of the main 
types of cells doing the actual fighting against the cancer cells. I named him Tim in order for his 
name to start with the same letter of the type of cell he is, “T.” Making it easier for the reader to 
remember what type of cell he is. I needed a Cytotoxic T cell in order to show the audience how 
these specific T cells can recognize the cancer markers on cancerous cells and cause their 
apoptosis, or cell death. Doing so by releasing their perforin, which penetrates the cancerous 
cell’s membrane, ultimately destroying the cell.  
Ava 
Ava is another type of T cell, although the hint of a “T” is not in her name. However, her name 
can be translated to “living one” or “joyful,” a personality I thought would be perfectly fitting for 
someone who loves to help. Therefore, Ava was created to be a helper T cell in my story. She is 
also a main character, for her role as a helper T cell is crucial in the organization and recruitment 
of other immune cells in the formation of an immune response against cancer. Which helper T 
cells accomplish by communicating with other cells by secreting chemical signals. Since she 
helps, I use her voice often throughout the story to explain the more complicated subjects, like 
science terms and settings or parts of the body.   
Neo 
A story about Acute Lymphoblastic Leukemia (ALL) needs an explanation for how this type of 
Leukemia started. For that I created the character of Neo, a newly made immature B cell born in 
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the red bone marrow like Tim. I wanted the audience to see one B cell that was born with the 
mutation, although multiple B cells in ALL can be born with a mutation at the same time. The 
purpose for Neo was not only to show how this mutation starts the replication of cancerous 
clones, but for the reader to see that these cells carrying the mutation are not evil cells. They are 
just cells who had something wrong with their DNA, even though they are called malignant, they 
are not to be feared. After all, like Neo, they can’t control the fact that they carry a mutation that 
causes ALL either.  
Bebel 
Bebel is a Natural Killer cell; these cells specialize in fighting virally infected cells and cancer 
cells. The reason for why I needed a Natural Killer cell in the story, is because Natural Killer 
cells are the first to encounter the cancerous clones or cells, and then call on T cells for help. As 
you can see on Bebel’s nucleus, he has multiple differently sized dots which represent the 
cytokines and toxic granules that this type of immune cell uses in order to penetrate the infected 
cell’s membrane and kill it.  
Brielle 
Brielle is a B cell who Ava calls upon to keep Neo company in the red bone marrow while her 
and Tim make their trip to the thymus. Brielle is a minor character in this story, but she is there 





Parts of Human Body and Settings for the Story 
Red Bone Marrow 
Both Red Blood Cells (RBCs) and White Blood Cells (WBCs) are created in the red bone 
marrow. Red bone marrow can be found in the majority of flat bones, like hip bones, and 
towards the heads or tips of long bones, like a femur (thigh bone) or humerus (arm bone). The 
red bone marrow is the main setting in my story, because ALL is cancer of the bone marrow. 
You can see that in the beginning of the story the red bone marrow background is red, but when 
Ava and Tim return it is more of a brown and bone color. This was my way of representing the 
cancer of the bone marrow and less RBCs being present. 
Blood Vessel (and Lymphatic System) 
In the story we see Tim and Ava traveling from a source of red bone marrow to the Thymus in 
order for Tim to mature. Blood vessels and the lymphatic system are what white blood cells use 
as a means of transportation through out every part of the body. For the sake of simplicity, I 
chose to illustrate this transportation as the inside of a tunnel-like structures representing the 
inside of blood vessels.  
Thymus 
The Thymus, located behind the breast bone, is the cite where an immature T cell matures, goes 
through selection and differentiates or identifies with a specific T cell role, depending on the 
antigen that is presented to it by an Antigen Presenting Cell. This location was important to the 
story, for it is where Tim matures and becomes a Cytotoxic T cell and is able to recognize the 
cells with the cancer marker. The scene in the Thymus is important for the reader to understand 
how specific roles are assigned to T cells. Ava in this story has already become a helper T cell 
and has been through this maturing and selection process herself. The reason for why I didn’t 
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show this for her though, was because I wanted her to be a mature cell from the start so that she 
could help Tim. 
Although these were the key settings for my story and plot, immune cells can be found 
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